Literature DB >> 16581313

Identification and sizing of GAA trinucleotide repeat expansion, investigation for D-loop variations and mitochondrial deletions in Iranian patients with Friedreich's ataxia.

Massoud Houshmand1, Mehdi Shafa Shariat Panahi, Shahriar Nafisi, Akbar Soltanzadeh, Fawziah M Alkandari.   

Abstract

Friedreich's Ataxia (FA) is the commonest genetic cause of ataxia and is associated with the expansion of a GAA repeat in intron 1 of the frataxin gene. Iron accumulation in the mitochondria of patients with FA would result in hypersensitivity to oxidative stress. Mitochondrial DNA (mtDNA) could be considered a candidate modifier factor for FA disease, since mitochondrial oxidative stress is thought to be involved in the pathogenesis of this disease. We studied 25 Iranian patients (16 females and 9 males) from 12 unrelated families. DNA from each patient was extracted and frequency and length of (GAA)(n) repeat was analyzed using a long-range polymerase chain reaction (PCR) test. Also we investigated impact of GAA size on neurological findings, age of onset and disease development. In order to identify polymorphic sites and genetic background, the sequence of two hypervariable regions (HVR-I and HVR-II) of mtDNA was obtained from FA patients harbouring GAA trinucletide expansions. Alignment was made with the revised cambridge reference sequence (rCRS) and any differences recorded as single base substitution (SBS), insertions and deletions. Homozygous GAA expansion was found in 21 (84%) of all cases. In four cases (16%), no expansion was observed, ruling out the diagnosis of Friedreich's ataxia. In cases with GAA expansions, ataxia, scoliosis and pes cavus, cardiac abnormalities and some neurological findings occurred more frequently than in our patients without GAA expansion. Molecular analysis was imperative for diagnosis of Friedreich's ataxia, not only for typical cases, but also for atypical ones. Diagnosis bases only on clinical findings is limited, however, it aids in better screening for suspected cases that should be tested. Our results showed that the rate of D-loop variations was higher in FA patients than control (P<0.05). mtDNA deletions were present in 76% of our patients representing mtDNA damage, which may be due to iron accumulation in mitochondria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581313     DOI: 10.1016/j.mito.2006.01.005

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  11 in total

1.  Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!

Authors:  Mohammad Mehdi Banoei; Massoud Houshmand; Mehdi Shafa Shariat Panahi; Parvin Shariati; Maryam Rostami; Masoumeh Dehghan Manshadi; Tayebeh Majidizadeh
Journal:  Cell Mol Neurobiol       Date:  2007-10-20       Impact factor: 5.046

2.  Association between trinucleotide CAG repeats of the DNA polymerase gene (POLG) with age of onset of Iranian Friedreich's ataxia patients.

Authors:  Mohammad Mehdi Heidari; Massoud Houshmand; Saman Hosseinkhani; Shahriar Nafissi; Barbara Scheiber-Mojdehkar; Mehri Khatami
Journal:  Neurol Sci       Date:  2008-11-28       Impact factor: 3.307

3.  A novel mitochondrial heteroplasmic C13806A point mutation associated with Iranian Friedreich's ataxia.

Authors:  Mohammad Mehdi Heidari; Massoud Houshmand; Saman Hosseinkhani; Shahriar Nafissi; Barbara Scheiber-Mojdehkar; Mehri Khatami
Journal:  Cell Mol Neurobiol       Date:  2008-09-19       Impact factor: 5.046

4.  Frataxin deficiency impairs mitochondrial biogenesis in cells, mice and humans.

Authors:  Mittal J Jasoliya; Marissa Z McMackin; Chelsea K Henderson; Susan L Perlman; Gino A Cortopassi
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

Review 5.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

6.  Molecular and clinical investigation of Iranian patients with Friedreich ataxia.

Authors:  Mohammad Hossein Salehi; Massoud Houshmand; Omid Aryani; Behnam Kamalidehghan; Elham Khalili
Journal:  Iran Biomed J       Date:  2014

7.  Is 8860 variation a rare polymorphism or associated as a secondary effect in HCM disease?

Authors:  Massoud Houshmand; Maryam Montazeri; Nafiseh Kuchekian; Freidoon Noohi; Givtaj Nozar; Akram Zamani
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

Review 8.  Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.

Authors:  Cláudio M Gomes; Renata Santos
Journal:  Oxid Med Cell Longev       Date:  2013-07-09       Impact factor: 6.543

9.  An Investigation on Mitochondrial DNA Deletions and Telomere Shortening during Multiple Passages of Adult Stem Cells.

Authors:  Farzaneh Fesahat; Mohammad Hasan Sheikhha; Azam Rasti; Fatemeh Sadeghian Nodoshan; Hadi Zare-Zardini; Ali Reza Navabazam
Journal:  Avicenna J Med Biotechnol       Date:  2014-07

10.  Deep sequencing of mitochondrial genomes reveals increased mutation load in Friedreich's ataxia.

Authors:  Angela D Bhalla; Alireza Khodadadi-Jamayran; Yanjie Li; David R Lynch; Marek Napierala
Journal:  Ann Clin Transl Neurol       Date:  2016-06-14       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.